Case Study Reports Temporary Speech Recovery in Alzheimer’s Patient After Psilocybin Dose, Effects Later Faded

An 80-year-old Japanese-American woman with severe Alzheimer’s disease, who had not spoken for five years, began speaking in full autobiographical conversations 19 hours after receiving a single 5-gram dose of Enigma strain psilocybin mushrooms, according to a case study published in Frontiers in Neuroscience.

The patient, previously non-verbal and isolated for years, talked for hours, recalled life memories, smiled, made eye contact, and showed gains in motor control and bladder function. These changes lasted for days and weeks after the initial dose.

One month later she received a second, smaller dose of the same mushrooms and experienced similar improvements. ” The report notes that the observed effects were temporary and that the findings come from a single case with stated limitations. The source of the report is identified as Yahoo News, writer Jamie.